These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15946204)

  • 1. The presence of IgG antibodies against beta2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant.
    Zoghlami-Rintelen C; Vormittag R; Sailer T; Lehr S; Quehenberger P; Rumpold H; Male C; Pabinger I
    J Thromb Haemost; 2005 Jun; 3(6):1160-5. PubMed ID: 15946204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the determination of anti-beta2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome?
    Hsieh K; Knöbl P; Rintelen C; Kyrle PA; Quehenberger P; Bialonczyk C; Partsch H; Lechner K; Pabinger I
    Br J Haematol; 2003 Nov; 123(3):490-5. PubMed ID: 14617012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis.
    Forastiero R; Martinuzzo M; Pombo G; Puente D; Rossi A; Celebrin L; Bonaccorso S; Aversa L
    J Thromb Haemost; 2005 Jun; 3(6):1231-8. PubMed ID: 15946213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
    Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
    Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of anticardiolipin antibodies, anti-beta2 glycoprotein I antibodies and lupus anticoagulant in a prospective longitudinal study of children with juvenile idiopathic arthritis.
    Avcin T; Ambrozic A; Bozic B; Accetto M; Kveder T; Rozman' B
    Clin Exp Rheumatol; 2002; 20(1):101-8. PubMed ID: 11892692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients.
    Gómez-Pacheco L; Villa AR; Drenkard C; Cabiedes J; Cabral AR; Alarcón-Segovia D
    Am J Med; 1999 Apr; 106(4):417-23. PubMed ID: 10225244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
    Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
    J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-beta2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant.
    Sailer T; Zoghlami C; Kurz C; Rumpold H; Quehenberger P; Panzer S; Pabinger I
    Thromb Haemost; 2006 May; 95(5):796-801. PubMed ID: 16676070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Relevance of Isolated Lupus Anticoagulant Positivity in Patients with Thrombotic Antiphospholipid Syndrome.
    Yin D; de Groot PG; Ninivaggi M; Devreese KMJ; de Laat B
    Thromb Haemost; 2021 Sep; 121(9):1220-1227. PubMed ID: 33385181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of anti-domain 1-β2 glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome.
    De Craemer AS; Musial J; Devreese KM
    J Thromb Haemost; 2016 Sep; 14(9):1779-87. PubMed ID: 27314634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-domain 1 of beta2-glycoprotein I aids risk stratification in lupus anticoagulant-positive patients.
    Guo H; Zhang Y; Li A; Wang C; Yang S; Zhang Y; Zhang J; Qiao R
    Clin Exp Med; 2019 Aug; 19(3):339-345. PubMed ID: 31093818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticardiolipin and anti-beta2glycoprotein-I antibodies in patients with systemic lupus erythematosus: comparison between Colombians and Spaniards.
    Cucurull E; Espinoza LR; Mendez E; Molina JF; Molina J; Ordi-Ros J; Gharavi AE
    Lupus; 1999; 8(2):134-41. PubMed ID: 10192508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
    Alving BM; Barr CF; Tang DB
    Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-beta2-glycoprotein I antibodies.
    Neville C; Rauch J; Kassis J; Solymoss S; Joseph L; Belisle P; Subang R; Chang ER; Fortin PR
    Rheumatology (Oxford); 2006 Sep; 45(9):1116-20. PubMed ID: 16510527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.